163 related articles for article (PubMed ID: 9454589)
1. Melanocortin receptor binding determinants in the agouti protein.
Kiefer LL; Veal JM; Mountjoy KG; Wilkison WO
Biochemistry; 1998 Jan; 37(4):991-7. PubMed ID: 9454589
[TBL] [Abstract][Full Text] [Related]
2. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
[TBL] [Abstract][Full Text] [Related]
4. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors.
Fong TM; Mao C; MacNeil T; Kalyani R; Smith T; Weinberg D; Tota MR; Van der Ploeg LH
Biochem Biophys Res Commun; 1997 Aug; 237(3):629-31. PubMed ID: 9299416
[TBL] [Abstract][Full Text] [Related]
5. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin receptors and antagonists regulate pigmentation and body weight.
Jordan SA; Jackson IJ
Bioessays; 1998 Aug; 20(8):603-6. PubMed ID: 9780833
[TBL] [Abstract][Full Text] [Related]
8. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.
Arasasingham PN; Fotsch C; Ouyang X; Norman MH; Kelly MG; Stark KL; Karbon B; Hale C; Baumgartner JW; Zambrano M; Cheetham J; Tamayo NA
J Med Chem; 2003 Jan; 46(1):9-11. PubMed ID: 12502354
[TBL] [Abstract][Full Text] [Related]
10. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of melanocortin receptor signaling mediated by the amino terminus of Agouti protein in Xenopus melanophores.
Ollmann MM; Barsh GS
J Biol Chem; 1999 May; 274(22):15837-46. PubMed ID: 10336487
[TBL] [Abstract][Full Text] [Related]
12. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
13. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
14. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
15. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
[TBL] [Abstract][Full Text] [Related]
16. Overview of endogenous and synthetic melanocortin peptides.
Wilson KR; Todorovic A; Proneth B; Haskell-Luevano C
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):3-20. PubMed ID: 16914082
[TBL] [Abstract][Full Text] [Related]
17. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
Siegrist W; Willard DH; Wilkison WO; Eberle AN
Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
[TBL] [Abstract][Full Text] [Related]
18. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
[TBL] [Abstract][Full Text] [Related]
19. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
[TBL] [Abstract][Full Text] [Related]
20. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
